Aktueller Stand der Long/Post-COVID-Therapie DOI
Jens Volkmann,

Vega Gödecke

Deleted Journal, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 18, 2024

Die Folgen einer SARS-CoV-2("severe acute respiratory syndrome coronavirus 2")-Infektion können die Lebensqualität der Betroffenen durch Symptome wie chronische Fatigue, Belastungsintoleranz, Dyspnoe und kognitive Dysfunktion stark beeinträchtigen. Dabei stellt Komplexität des Post-COVID("coronavirus disease")-Syndroms eine große klinische Herausforderung dar, nicht nur bezüglich Eingrenzung pathophysiologischen Grundlagen, sondern auch im Hinblick auf Einleitung gezielter wirksamer Therapien. Aufgrund hohen Leidensdrucks werden in Ermangelung therapeutischer Alternativen verschiedene Verfahren Plasmapherese, Lipoproteinapherese Immunadsorption eingesetzt, um Fatigue Belastungsintoleranz zu lindern. Wirksamkeit dieser ist jedoch beim Post-COVID-Syndrom noch ausreichend untersucht. derzeit laufenden randomisierten, placebokontrollierten Studien zielen darauf ab, Wirkung von Immunadsorptionsbehandlungen andere Parameter untersuchen sowie Marker für das Ansprechen Behandlung identifizieren.

Anästhesie bei Patient:innen mit postviralen Erkrankungen DOI Creative Commons
Thomas Michael Weber

Schmerz Nachrichten, Journal Year: 2025, Volume and Issue: unknown

Published: March 20, 2025

Citations

0

Modellierung der COVID-Infektionszahlen in Deutschland (2020–2024) DOI Creative Commons

Dirk Paessler,

Martin Hechler,

P. Richard Verbeek

et al.

Notfall + Rettungsmedizin, Journal Year: 2025, Volume and Issue: unknown

Published: April 3, 2025

Citations

0

Barriers and facilitators of healthcare access for long COVID-19 patients in a universal healthcare system: qualitative evidence from Austria DOI Creative Commons
Peter Gamillscheg, Agata Łaszewska, Stefanie Kirchner

et al.

International Journal for Equity in Health, Journal Year: 2024, Volume and Issue: 23(1)

Published: Oct. 23, 2024

Long COVID-19 challenges health and social systems globally. International research finds major inequalities in prevalence healthcare utilization as patients describe difficulties with accessing care. In order to improve long-term outcomes it is vital understand any underlying access barriers, for which relevant evidence on long thus far lacking a universal system like Austria. This study aims comprehensively identify barriers facilitators faced by Austria explore potential socioeconomic demographic drivers care access. Applying an exploratory qualitative approach, we conducted semi-structured interviews 15 experts including medical professionals senior officials well focus groups 18 confirmed diagnosis reflecting varying participant characteristics (age, gender, urbanicity, occupation, education, insurance status) (July-Nov 2023). Data were analysed following thematic framework drawing comprehensive 'access care' model. Based expert patient experiences, several emerged along all dimensions of the Main themes included scepticism stigma professionals, finding knowledgeable doctors, limited specialist capacities ambulatory sector, waiting times care, statutory coverage treatments resulting high out-of-pocket payments. Patients experienced constant self-organization their pathway stressful, emphasizing need multidisciplinary centralized coordination. Facilitators supportive environments, telemedicine, informal information provided nationwide patient-led support group. Differences experiences emerged, among others, women younger gender- age-based stigmatization. Complementary reduced financial strain, however, did not ease capacity constraints, particularly challenging those living rural areas. The findings this indicate call action situation empowering both providers via increased offerings, strengthened interdisciplinary treatment structures telemedicine offerings funding. Our insights potentially lay necessary foundation future quantitative inequality research.

Language: Английский

Citations

3

Overlapping conditions in Long COVID at a multisite academic center DOI Creative Commons
Stephanie L. Grach, Daniel V. Dudenkov,

Beth Pollack

et al.

Frontiers in Neurology, Journal Year: 2024, Volume and Issue: 15

Published: Oct. 25, 2024

Many patients experience persistent symptoms after COVID-19, a syndrome referred to as Long COVID (LC). The goal of this study was identify novel new or worsening comorbidities self-reported in with LC.

Language: Английский

Citations

1

Barriers and facilitators of healthcare access for long COVID-19 patients in a universal healthcare system: Qualitative evidence from Austria DOI
Peter Gamillscheg, Agata Łaszewska, Stefanie Kirchner

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: July 19, 2024

Abstract Background: Long COVID-19 challenges health and social systems globally. International research finds major inequalities in prevalence healthcare utilization as patients describe difficulties with accessing care. In order to improve long-term outcomes it is vital understand any underlying access barriers, for which relevant evidence on long COVID-19 thus far lacking a universal system like Austria. This study aims comprehensively identify barriers facilitators faced by Austria explore potential socioeconomic demographic drivers care access. Methods: Applying an exploratory qualitative approach, we conducted semi-structured interviews 15 experts including medical professionals senior officials well focus groups 18 confirmed diagnosis reflecting varying participant characteristics (age, gender, urbanicity, occupation, education, insurance status) (July-Nov 2023). Data were analysed following thematic framework drawing comprehensive ‘access care’ model. Results: Based expert patient experiences, several emerged along all dimensions of the Main themes included scepticism stigma professionals, finding knowledgeable doctors, limited specialist capacities ambulatory sector, waiting times care, statutory coverage treatments resulting high out-of-pocket payments. Patients experienced constant self-organization their pathway stressful, emphasizing need multidisciplinary centralized coordination. Facilitators supportive environments, telemedicine, informal information provided nationwide patient-led support group. Differences experiences emerged, among others, women younger gender- age-based stigmatization. Complementary reduced financial strain, however, did not ease capacity constraints, particularly challenging those living rural areas. Conclusions: The findings this indicate call action situation empowering both providers via increased offerings, strengthened interdisciplinary treatment structures funding. Our insights potentially lay necessary foundation future quantitative inequality research.

Language: Английский

Citations

0

Aus dem Leben gerissen – Postakute Infektionssyndrome nach Covid-19 DOI
Verena Hackl, Kathryn Hoffmann

physiopraxis, Journal Year: 2024, Volume and Issue: 22(09), P. 36 - 39

Published: Sept. 1, 2024

Mit den vielen Covid-19-Erkrankungen in letzten Jahren steigen auch die Langzeitfolgen dieser Infektion. Dazu zählen unter anderem das posturale Tachykardiesyndrom, eine Dysfunktion des autonomen Nervensystems, und Post-Exertional Malaise. unzähligen kardiovaskulären muskuloskelettalen, aber neurologischen Symptomen sind viele Patient*innen häufig nicht mehr der Lage, ihren Alltag zu bestreiten.

Citations

0

“A bit of a cough, tired, not very resilient – is that already Long-COVID?” perceptions and experiences of GPs with Long-COVID in year three of the pandemic. a qualitative interview study in Austria DOI Creative Commons
Silvia Wojczewski,

Mira Mayrhofer,

Nathalie Szabo

et al.

BMC Public Health, Journal Year: 2024, Volume and Issue: 24(1)

Published: Nov. 7, 2024

Long-COVID is a new multisectoral healthcare challenge. This study aims at understanding experiences, knowledge, attitudes and (information) needs that GPs had have in relation to how these evolved since the beginning of COVID-19 pandemic.

Language: Английский

Citations

0

Aktueller Stand der Long/Post-COVID-Therapie DOI
Jens Volkmann,

Vega Gödecke

Deleted Journal, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 18, 2024

Die Folgen einer SARS-CoV-2("severe acute respiratory syndrome coronavirus 2")-Infektion können die Lebensqualität der Betroffenen durch Symptome wie chronische Fatigue, Belastungsintoleranz, Dyspnoe und kognitive Dysfunktion stark beeinträchtigen. Dabei stellt Komplexität des Post-COVID("coronavirus disease")-Syndroms eine große klinische Herausforderung dar, nicht nur bezüglich Eingrenzung pathophysiologischen Grundlagen, sondern auch im Hinblick auf Einleitung gezielter wirksamer Therapien. Aufgrund hohen Leidensdrucks werden in Ermangelung therapeutischer Alternativen verschiedene Verfahren Plasmapherese, Lipoproteinapherese Immunadsorption eingesetzt, um Fatigue Belastungsintoleranz zu lindern. Wirksamkeit dieser ist jedoch beim Post-COVID-Syndrom noch ausreichend untersucht. derzeit laufenden randomisierten, placebokontrollierten Studien zielen darauf ab, Wirkung von Immunadsorptionsbehandlungen andere Parameter untersuchen sowie Marker für das Ansprechen Behandlung identifizieren.

Citations

0